The acquisition of a new patent, especially in a significant market like Europe, typically enhances a company's intellectual property portfolio, potentially leading to new product developments or partnerships. This could positively impact investor sentiment and FNCH's stock price in the short term, as it demonstrates progress in expanding its treatment offerings and securing its market position.